EDGAR Filing Documents for 0001209191-22-039048

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001209191-22-039048

Filing Date

2022-06-23

Accepted

2022-06-23 18:09:13

Documents

Period of Report

2022-06-21

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4 SUBMISSION	doc4.html	4
1	FORM 4 SUBMISSION	doc4.xml	4	4032
	Complete submission text file	0001209191-22-039048.txt		5524

Mailing Address 210 EAST GRAND AVE. SOUTH SAN FRANCISCO CA 94080

Business Address

Type: 4 | Act: 34 | File No.: 001-40431 | Film No.: 221036549

Mailing Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930

Business Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930 206-913-4300

Day One Biopharmaceuticals, Inc. (Issuer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations